Medical/Pharmaceuticals News & Press Release Distribution

Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications

BEIJING, June 23, 2026 /PRNewswire/ -- On June 23, 2026 (Beijing time), Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement withNuvectis, a U.S. biotechnology company. Under the agreement, Haisco has granted Nuvectis the ...

2026-06-23 21:17 6192

Chenwei Medical Showcases Advanced ICU Ventilators, Anesthesia Workstations and Emergency Transport Ventilator Solutions at WHX Miami 2026

MIAMI, June 23, 2026 /PRNewswire/ -- Following its participation in the AMCI International Critical Care Congress in Colombia, Chenwei Medical presented its latest innovations in ICU ventilation, anesthesia systems and emergency respiratory care at WHX Miami 2026.

2026-06-23 21:12 6527

Chenwei Medical Showcases Advanced ICU Ventilators, Anesthesia Workstations and Emergency Transport Ventilator Solutions at WHX Miami 2026

EpiVax Announces Laboratory Expansion and Streamlined, NAM-Centric In Vitro Services

PROVIDENCE, R.I., June 23, 2026 /PRNewswire/ -- EpiVax, Inc., a recognized leader in immunogenicity risk assessment, announces the expansion of its laboratory facilities at its Providence, RI headquarters. The upgraded space has more than doubled the company's laboratory footprint, expanding the ...

2026-06-23 21:12 4547

Ambulatory Surgical Centres Poised for Sustained Growth as Healthcare Delivery Continues to Shift Beyond the Hospital

Frost & Sullivan identifies significant opportunities across ambulatory surgery, digital health, and connected care markets LONDON, June 23, 2026 /PRNewswire/ -- Frost & Sullivan's latest analysis highlights ambulatory surgical centres (ASCs) as one of the most significant growth opportunities r...

2026-06-23 20:17 5380

Fair Play Menarini International Award

Diego Milito and Emilio Butragueño among the winners of the 30th edition FLORENCE, Italy, June 23, 2026 /PRNewswire/ -- The list of winners of the 30th Fair Play Menarini International Award, scheduled forJuly 2 in Florence, continues to include great legends of world sport. Among the champions w...

2026-06-23 18:29 3169

Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity

* Phase I trial consists of two parts. Part A is a single ascending dose (SAD) study of ASC35 once-monthly Self-Assembling Lipid Depot (SALD) formulation; Part B is a head-to-head study of multiple ascending doses (MAD) of ASC35 once-monthly SALD formulation compared to the U.S. Food and Drug ...

2026-06-23 18:10 7495

CPHI/ Hi Korea 2026 Opens Pre-Registration: Korea's Hub for Pharma, Biopharma, and Health Innovation

SEOUL, South Korea, June 23, 2026 /PRNewswire/ -- Informa Markets Korea has officially opened pre-registration for CPHI/ Hi Korea 2026, taking place at COEX, Seoul, from August 25 to 27. Pre-registered visitors enjoy complimentary entries.

2026-06-23 08:00 8594

CPHI/ Hi Korea 2026 Opens Pre-Registration: Korea's Hub for Pharma, Biopharma, and Health Innovation

DoH and Sanofi Partner to Advance Vaccine Innovation

ABU DHABI, UAE, June 23, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Sanofi, a worldwide biopharma and vaccines leader, have signed an Memorandum of Understanding and intend to into an agreement to advance their partner...

2026-06-23 07:47 9978

DoH and Sanofi Partner to Advance Vaccine Innovation

Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

MELBOURNE, Australia and INDIANAPOLIS, June 23, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces an educational webinar exploring the unmet needs in neurologic oncology (specifically glioma and glioblastoma) and how theranostics may help address ...

2026-06-23 05:37 8867

Texas A&M Study Highlights Pictor PictVet® as a Promising New Tool for Non-Invasive Beef Cattle Health Monitoring

Independent peer-reviewed research published in Frontiers in Veterinary Science reports strong assay performance in a proof-of-concept evaluation using bovine nasopharyngeal swab samples CARLSBAD, Calif., June 23, 2026 /PRNewswire/ -- Pictor Holdings Inc., a global targeted proteomic platform co...

2026-06-23 01:37 5089

Biomerics Appoints Kristin Mason as Chief Financial Officer

SALT LAKE CITY, June 22, 2026 /PRNewswire/ -- Biomerics, a leading vertically integrated contract manufacturer for the interventional medical device market, today announced the appointment of Kristin Mason as Chief Financial Officer. Mason joins Biomerics following an extensive career leading fin...

2026-06-22 22:03 5977

Laboratoires Pierre Fabre receives European Commission Approval for BRAFTOVI® (encorafenib) in combination with cetuximab and FOLFOX (fluorouracil, leucovorin, and oxaliplatin) for the first-line treatment of adult patients with BRAFV600E-mutant metastatic colorectal cancer (mCRC)

* European approval is based on results from the Phase 3 BREAKWATER trial, which demonstrated that encorafenib in combination with cetuximab and mFOLFOX6 demonstrated a statistically significant improvement in the dual primary endpoints of objective response rate (ORR) and progression-free sur...

2026-06-22 21:14 6165

Sisram Medical Bolsters EBD and Injectables in Thailand to Unlock APAC Growth

With advancing EBD rollout and steady injectables expansion, integrated treatment protocols deliver unique competitive edges for high-quality regional growth HONG KONG, June 22, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-...

2026-06-22 20:16 9651

Sisram Medical Bolsters EBD and Injectables in Thailand to Unlock APAC Growth

With advancing EBD rollout and steady injectables expansion, integrated treatment protocols deliver unique competitive edges for high-quality regional growth HONG KONG, June 22, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global wellness group offering Energy-...

2026-06-22 20:11 10206

CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors

SHANGHAI, June 22, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that as informed by the National Medical Products Administration ("NMPA") today, the New Drug Application ("NDA") of sat...

2026-06-22 19:33 8841

CARsgen Announces Approval of Satri-cel, the World's First CAR T-Cell Therapy Product for Solid Tumors

SHANGHAI, June 22, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that as informed by the National Medical Products Administration ("NMPA") today, the New Drug Application ("NDA") of sat...

2026-06-22 19:20 6842

ChemT Biotechnology Raises US$5 Million in 18 months to bring AI to Biomanufacturing

* The total funding comprises US$1 million in angel investment and a US$4 million seed round. The seed financing round was led by Wavemaker Ventures, with participation by SEEDS, further supported by notable investors across the United States and Asia. * The financing will support the continu...

2026-06-22 17:15 5324

Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits

* Piramal Pharma Solutions completed more than 200 customer audits and received over 70 approvals from regulatory agencies across its global network over the past year, with strong overall outcomes. * This milestone reflects the Company's long-range quality strategy focused on sustained compl...

2026-06-22 16:57 5641

Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits

Innogen Pharmaceutical Group Highlights China-Originated Innovation and Global Development Strategy at DIA Global Annual Meeting 2026 China Town Hall

From original GLP-1 science to international clinical development, Innogen shares its "from 0 to 1" innovation journey in metabolic diseases PHILADELPHIA, June 22, 2026 /PRNewswire/ -- During the DIA Global Annual Meeting 2026 held in Philadelphia, the China Town Hall session was successfully co...

2026-06-22 16:39 4727

Innogen Pharmaceutical Group Highlights China-Originated Innovation and Global Development Strategy at DIA Global Annual Meeting 2026 China Town Hall

Translational Research Results of Sacituzumab Tirumotecan (sac-TMT) in Combination with Osimertinib as First-Line Treatment for EGFR-Mutant NSCLC Published in Cancer Cell

— The study shows that EGFR-TKIs induce TROP2 upregulation in DTP cells, providing a mechanistic basis for combining sac-TMT with EGFR-TKI. — The Company is conducting a Phase III registrational study of sac-TMT plus osimertinib as first-line treatment for advanced EGFR-mutant NSCLC (enrollment ...

2026-06-22 14:00 8797